THETFORD MINES, QUEBEC--(Marketwired - Jan. 6, 2016) - AlliancePharma Inc. (TSX VENTURE:APA) ("AlliancePharma" or "the Company") launches Logistik Pharma, a new subsidiary dedicated to increasing the profitability of pharmacies by optimizing laboratory work organization and patient management. This new integrated optimization process aims to improve the quality of pharmaceutical services to patients, while increasing the profitability of the pharmacy.
"AlliancePharma stands out as a leader in professional services and wishes to offer all pharmacies in Quebec a wide range of resources and powerful tools allowing them to tap into new market trends. By improving their laboratory structure, pharmacists will be able to maximize profitability at all stages of the process while improving the quality of life of their patients", said Marc Lemieux, Chairman of the Board, President and CEO of AlliancePharma.
Greater pharmacy efficiency
Logistik Pharma reviews all activities performed in the laboratory, from inventory management to the content delegation through the support of patients services and workflow enhancement.
Logistik Pharma also offers training services involving the integration of new acts arising out of Bill 41, the establishment of compliance procedures, as well as patient follow up and billing.
About AlliancePharma
AlliancePharma is the leader in professional services and replacement pharmacists and pharmacy technicians in Quebec. The quality of its customer service and professional services rendered reflect the expertise of the Company. Management's vision is to expand and diversify its activities to become a key player in the health services industry in Quebec, the rest of Canada and internationally. Additional information regarding the Company is available at www.alliancepharmainc.ca and on SEDAR at www.sedar.com.
This press release contains forward-looking statements to which are associated some risks and uncertainties. Any statement contained in this present press release that does not constitute an historical fact can be considered as a forward-looking statement. Those statements do not warrant as for the future performance of AlliancePharma Inc. and they suppose known and unknown risks as well as uncertainties in such a way that true future perspectives, returns or results of the Company may be different of future returns or results expressed or implied by these forward-looking statements. AlliancePharma Inc. does not accept responsibility for the accuracy and the completeness of those forward-looking statements and does not undertake to publicly review such statements to adapt to new events or circumstance.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.